Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Guhl

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Actas Dermo-Sifiliograficas|January 22, 2008
[Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab]G Guhl, B Díaz-Ley, J Fernández-Herrera
Actas Dermo-Sifiliograficas|November 24, 2007
[Off-label use of biologic agents in the treatment of dermatosis, Part 1: infliximab and adalimumab]B Díaz-Ley, G Guhl, J Fernández-Herrera
Clinical and Experimental Dermatology|December 21, 2006
Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockersR Goiriz, E Daudén, S Pérez-Gala, et al.
Clinical and Experimental Dermatology|December 2, 2008
Wegener's granulomatosis: a new entity in the growing differential diagnosis of Degos' diseaseG Guhl, B Diaz-Ley, Y Delgado, et al.
British Journal of Haematology|December 29, 2007
Flexural cutaneous eruption due to paliferminB Diaz Ley, G Guhl, C Eguren Michelena, et al.
Actas Dermo-Sifiliograficas|December 19, 2006
[Mondor's disease]A Juárez, S Pérez-Gala, G Guhl, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|January 1, 1982
[Cutaneous malignant melanomas. A study of 13 cases observed in a general surgery department (author's transl)]A Yangni-Angate, J Khoury, M Kanga, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Actas Dermo-Sifiliograficas|January 22, 2008
[Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab]G Guhl, B Díaz-Ley, J Fernández-Herrera
Actas Dermo-Sifiliograficas|November 24, 2007
[Off-label use of biologic agents in the treatment of dermatosis, Part 1: infliximab and adalimumab]B Díaz-Ley, G Guhl, J Fernández-Herrera
Clinical and Experimental Dermatology|December 21, 2006
Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockersR Goiriz, E Daudén, S Pérez-Gala, et al.
Clinical and Experimental Dermatology|December 2, 2008
Wegener's granulomatosis: a new entity in the growing differential diagnosis of Degos' diseaseG Guhl, B Diaz-Ley, Y Delgado, et al.
British Journal of Haematology|December 29, 2007
Flexural cutaneous eruption due to paliferminB Diaz Ley, G Guhl, C Eguren Michelena, et al.
Actas Dermo-Sifiliograficas|December 19, 2006
[Mondor's disease]A Juárez, S Pérez-Gala, G Guhl, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|January 1, 1982
[Cutaneous malignant melanomas. A study of 13 cases observed in a general surgery department (author's transl)]A Yangni-Angate, J Khoury, M Kanga, et al.
Pageof 1